Ceangail le linn

Sláinte

Comhdháil dhomhanda ar PM amárach, ritheadh ​​tionscnaimh sláinte poiblí-príobháideacha agus cúram sláinte trasteorann

ROINN:

foilsithe

on

Úsáidimid do shíniú suas chun ábhar a sholáthar ar bhealaí ar thoiligh tú leo agus chun ár dtuiscint ortsa a fheabhsú. Is féidir leat díliostáil ag am ar bith.

Good afternoon, and welcome to the latest update from the European Alliance for Personalised Medicine (EAPM). The virtual EAPM conference hits tomorrow (27 October), Denis Horgan, Stiúrthóir Feidhmiúcháin EAPM.

EAPM Global virtual conference: Last calls to register 

Tomorrow, on 27 October, a virtual conference/webinar will take place, run by EAPM. The banner title is 'A destination in sight: Doing it right to bring personalised health care to patients’. More than 150 delegates are registered for the global conference from countries such as China, Japan, Brazil, Egypt, Canada, Ghana, US and of course the EU. You can register anseo agus cliceáil ar an nasc chun an clár oibre a fheiceáil anseo.

Due to COVID 19 and a perfect storm in healthcare policy, the chance exists to re-align priorities to evaluate the needs of patients, healthcare professionals and health systems to facilitate improved and safer therapies.  There is also space and necessity for enhanced collaboration between regulatory and payer groups. This would have the aim of identifying core outcomes other than survival that can be incorporated into trials, as well as healthcare systems, to generate data throughout the lifecycle.

I measc nithe eile, cuirfidh an chomhdháil na ceisteanna seo a leanas:

  • How can we reconcile rapid access to innovation while incentivising necessary continued research to demonstrate value and societal benefits of new medical products, including IVDs?
  • What are the differences that affect regulatory vs payer decisions in different regions?
  • Cad iad na heilimintí sonraí ar leith a cheadódh measúnú éifeachtach a dhéanamh ar tháirgí a thabharfadh leas suntasach d’othair?
  • Can we find an agreed global approach to quantifying clinical benefit?
  • An bhfuil torthaí cliniciúla ann seachas maireachtáil a bhféadtar a chomhaontú le húsáid i dtrialacha clárúcháin agus i gcórais chúram sláinte?
  •  Conas is fearr a mhínímid an gá atá le taighde cliniciúil agus bailiú sonraí leanúnach d’othair agus don tsochaí agus an leas a bhaineann sé astu araon?

We look forward very much to seeing you there! You can register anseo agus cliceáil ar an nasc chun an clár oibre a fheiceáil anseo.

Nine public-private partnership initiatives passed

Aiseolas

The European Parliament has voted through nine public-private partnerships under Horizon Europe, which MEPs hope will shape up to be more accessible for small companies, be less bureaucratic and attract further funding from national and European programmes. 

“We were guided by the principles of openness, transparency and inclusiveness, which we want to be cross-cutting right across these partnerships,” said the rapporteur for the file, Maria da Graça Carvalho MEP. Parliament’s goal is to ensure effective spending of the €22 billion budget for the nine so-called joint undertakings, of which €10 billion will come from the EU research programme, Horizon Europe. 

The partnerships will launch a year after the start of Horizon Europe, once the member states give final approval. That is a formality, given they already reached an agreement among themselves in September. 

Parliament’s opinion is non-binding, but the vote will allow member states to officially adopt the legislation at a Council meeting at the end of November. Two of the partnerships, the Innovative Health Initiative and Global Health, will cover drug development in Europe and Africa. 

Cross-border health care - Is it a reality for patients? 

The right for EU citizens to seek health care outside their home country elsewhere in the bloc is enshrined in law. But the rules need changing in order to function better, Croatian MEP Tomislav Sokol of the European People’s Party has said. Tomislav Sokol, a Croatian Christian-democrat MEP, explained at a recent event, “If you cannot get adequate treatment for certain diseases, especially rare diseases in your country, you’re entitled to get this treatment in other member states to be covered by your own health insurance,” adding that many patients are not aware that such a document exists. 

Sokol added that patients are required to pay for the treatment upfront “and then ask for reimbursement afterwards from their home system, which is a big problem.” He said that “especially rare diseases are one of these areas where the member states cannot resolve problems by themselves, and they need help at the European level.”

At present, patients in the EU are able to go to another country to seek treatment under two different EU rules. They can seek treatment through the Cross-Border Healthcare Directive, which involves paying up-front for treatment and seeking reimbursement back home afterwards. 

“Cross-border health is just not utilized enough,” said Sokol. “There’s many reasons for this: people are not aware of the possibilities that exist; the procedure is very complicated and takes a long time.”

Sokol has said that there are three major ways to improve the existing rules. The chéad is to move authorization rules that are currently in the cross-border health directive into the social security coordination regulation. The merger would simplify reimbursement for patients, and put it on a firmer legal basis. The an dara togra is a right to a second opinion. Patients would be able to go abroad to ask experts whether they need treatment in another EU country in cases where local doctors are reluctant. The third fix sought by Sokol is for countries to do more to inform patients about their rights to cross-border health care and to help them in the process

This is an issue that EAPM will follow closely. 

EUCO conclusions

The meeting of EU leaders that ended on Friday (22 October) offered no surprises when it came to coronavirus. Leaders want further co-ordination on travel into and within the EU; the conclusion of negotiations on the health union package; removal of obstacles hampering the global roll-out of vaccines and support for a pandemic treaty. 

Slovenia launches ‘traffic light’ system for startup policy

Slovenia will launch a new system to evaluate EU states’ startup policy today (26 October). The policy programs to support startups are very different across the bloc. The Commission has no competence over crucial parts, such as hiring non-EU staff — which touches upon migration policy — or rewards, which relates to taxation. EU states are officially in charge, but the Commission can try to harmonize the process. 

The “traffic light” system adopted by Slovenia, which currently holds the Council’s presidency, is a visual summary of how EU states perform on five categories: Funding for startups; setting up advanced tech and climate tech startups; attracting talent; going global and working together with big corporations.

An tAcht um Margaí Digiteacha

This week will codify the Parliament’s position on the EU’s digital competition rules, known as the Digital Markets Act. The economic affairs committee is due to vote on its position today, and the industry committee on Thursday (28 October). The Digital Markets Act (DMA) establishes a set of narrowly defined objective criteria for qualifying a large online platform as a so-called “gatekeeper”. This allows the DMA to remain well targeted to the problem that it aims to tackle as regards large, systemic online platforms. These criteria will be met if a company:

  • Has a strong economic position, significant impact on the internal market and is active in multiple EU countries;
  • has a strong intermediation position, meaning that it links a large user base to a large number of businesses, and;
  • has (or is about to have) an entrenched and durable position in the market, meaning that it is stable over time. 

And that is all from EAPM for today – don’t forget, you can register for tomorrow’s EAPM conference anseo agus cliceáil ar an nasc chun an clár oibre a fheiceáil anseo. Stay safe, enjoy the conference!

Comhroinn an t-alt seo:

Foilsíonn Tuairisceoir an AE ailt ó fhoinsí éagsúla seachtracha a chuireann raon leathan dearcthaí in iúl. Ní gá gur seasaimh Tuairisceoir an AE iad na seasaimh a ghlactar sna hairteagail seo.

trending